Search Results - "SMIT, Frank P"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Prostate cancer biomarker profiles in urinary sediments and exosomes by Dijkstra, Siebren, Birker, Ingrid L, Smit, Frank P, Leyten, Gisele H J M, de Reijke, Theo M, van Oort, Inge M, Mulders, Peter F A, Jannink, Sander A, Schalken, Jack A

    Published in The Journal of urology (01-04-2014)
    “…Urinary biomarker tests for diagnosing prostate cancer have gained considerable interest. Urine is a complex mixture that can be subfractionated. We evaluated…”
    Get more information
    Journal Article
  5. 5

    Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer by HESSELS, Daphne, SMIT, Frank P, VERHAEGH, Gerald W, WITJES, J. Alfred, CORNET, Erik B, SCHALKEN, Jack A

    Published in Clinical cancer research (01-09-2007)
    “…Purpose: Early detection of prostate cancer can increase the curative success rate for prostate cancer. We studied the diagnostic usefulness of TMPRSS2-ERG…”
    Get full text
    Journal Article
  6. 6

    Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients by Hendriks, Rianne J., Dijkstra, Siebren, Smit, Frank P., Vandersmissen, Johan, Van de Voorde, Hendrik, Mulders, Peter F. A., van Oort, Inge M., Van Criekinge, Wim, Schalken, Jack A.

    Published in The Prostate (01-04-2018)
    “…Background : Noninvasive biomarkers to guide personalized treatment for castration‐resistant prostate cancer (CRPC) are needed. In this study, we analyzed…”
    Get full text
    Journal Article
  7. 7

    Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder by Luna‐Velez, Maria V., Dijkstra, Jelmer J., Heuschkel, Marina A., Smit, Frank P., van de Zande, Guillaume, Smeets, Dominique, Sedelaar, J. P. Michiel, Vermeulen, Michiel, Verhaegh, Gerald W., Schalken, Jack A.

    Published in Molecular oncology (01-07-2021)
    “…Bladder urothelial cell carcinoma (UCC) incidence is about three times higher in men compared with women. There are several indications for the involvement of…”
    Get full text
    Journal Article
  8. 8

    The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer by Groen, Levi, Yurevych, Viktor, Ramu, Harshitha, Chen, Johnny, Steenge, Lianne, Boer, Sabrina, Kuiper, Renske, Smit, Frank P, Verhaegh, Gerald W, Mehra, Niven, Schalken, Jack A

    Published in Non-coding RNA (01-12-2022)
    “…Castration resistance is the leading cause of death in men with prostate cancer. Recent studies indicate long noncoding RNAs (lncRNAs) to be important drivers…”
    Get full text
    Journal Article
  9. 9

    Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients by Verhaegh, Gerald W., de Jong, Arjan S., Smit, Frank P., Jannink, Sander A., Melchers, Willem J.G., Schalken, Jack A.

    Published in The Prostate (01-03-2011)
    “…BACKGROUND The occurrence of the retrovirus xenotropic murine leukemia virus (MLV)‐related virus (XMRV) has been reported in prostate tissue of patients with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics by Visser, Wieke C. H., de Jong, Hans, Smit, Frank P., Shrivastava, Jolly, Poole, Jason C., Leenders, William P. J., Melchers, Willem J. G., Mulders, Peter F. A., Schalken, Jack A.

    “…Microarray and Single-Molecule Molecular Inversion Probe (smMIP)-based targeted RNA sequencing are two RNA profiling platforms for identifying…”
    Get full text
    Journal Article
  12. 12

    miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 by van Kampen, Jasmijn G M, van Hooij, Onno, Jansen, Cornelius F, Smit, Frank P, van Noort, Paula I, Schultz, Iman, Schaapveld, Roel Q J, Schalken, Jack A, Verhaegh, Gerald W

    Published in Cancer research (Chicago, Ill.) (15-04-2017)
    “…Reversing epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic…”
    Get full text
    Journal Article
  13. 13

    Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer by Pfeiffer, Minja J, Smit, Frank P, Sedelaar, John P M, Schalken, Jack A

    Published in Molecular medicine (Cambridge, Mass.) (01-01-2011)
    “…Considerable levels of testosterone and dihydrotestosterone (DHT) are found in prostate cancer (PCa) tissue after androgen deprivation therapy. Treatment of…”
    Get full text
    Journal Article
  14. 14

    High‐resolution ERG‐expression profiling on GeneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer by Smit, Frank P., Salagierski, Maciej, Jannink, Sander, Schalken, Jack A.

    Published in BJU international (01-05-2013)
    “…Objective To assess whether oestrogen‐regulated gene (ERG) expression analysis using GeneChip arrays can predict transmembrane protease, serine 2 (TMPRSS2)‐ERG…”
    Get full text
    Journal Article
  15. 15

    Dutasteride and Enzalutamide Synergistically Suppress Prostate Tumor Cell Proliferation by Hamid, Agus Rizal A.H, Verhaegh, Gerald W, Smit, Frank P, van Rijt-van de Westerlo, Cindy, Armandari, Inna, Brandt, Andre, Sweep, Fred C.G.J, Sedelaar, John P.M, Schalken, Jack A

    Published in The Journal of urology (01-03-2015)
    “…Purpose Dihydrotestosterone is the main active androgen in the prostate and it has a role in prostate cancer progression. After androgen deprivation therapy…”
    Get full text
    Journal Article
  16. 16

    DD3 : A new prostate-specific gene, highly overexpressed in prostate cancer by BUSSEMAKERS, M. J. G, VAN BOKHOVEN, A, VERHAEGH, G. W, SMIT, F. P, KARTHAUS, H. F. M, SCHALKEN, J. A, DEBRUYNE, F. M. J, NING RU, ISAACS, W. B

    Published in Cancer research (Chicago, Ill.) (01-12-1999)
    “…Prostate cancer is the most commonly diagnosed malignancy and the second leading cause of cancer-related deaths in the Western male population. Despite the…”
    Get full text
    Journal Article
  17. 17

    Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer by Salagierski, Maciej, Verhaegh, Gerald W., Jannink, Sander A., Smit, Frank P., Hessels, Daphne, Schalken, Jack A.

    Published in The Prostate (01-01-2010)
    “…BACKGROUND PCA3 is one of the most prostate cancer (PrCa)‐specific markers described so far. Recently, a new genomic structure of PCA3 as well as new flanking…”
    Get full text
    Journal Article
  18. 18

    Broadband Diversity Antenna Array for UHF Digital TV by Edson T. C., Dos Santos, Daniel H. M., De Souza, Perotoni, Marcelo B., Bordin, Claudio J., Vieira, Marcos S., Frank L. P., Smit, Akamine, Cristiano

    “…This article describes the design and test of a UHF broadband array antenna for applications in Digital Terrestrial TV Broadcasting (DTTB) TV 3.0 project…”
    Get full text
    Conference Proceeding
  19. 19

    The Androgen Regulated lncRNA INAALADL2-AS2/I Promotes Tumor Cell Survival in Prostate Cancer by Groen, Levi, Yurevych, Viktor, Ramu, Harshitha, Chen, Johnny, Steenge, Lianne, Boer, Sabrina, Kuiper, Renske, Smit, Frank P, Verhaegh, Gerald W, Mehra, Niven, Schalken, Jack A

    Published in Non-coding RNA (01-12-2022)
    “…Castration resistance is the leading cause of death in men with prostate cancer. Recent studies indicate long noncoding RNAs (lncRNAs) to be important drivers…”
    Get full text
    Journal Article
  20. 20